# Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

> **NCT00198328** · PHASE3 · TERMINATED · sponsor: **Inovio Pharmaceuticals** · enrollment: 84 (actual)

## Conditions studied

- Head Neck Cancer

## Interventions

- **COMBINATION_PRODUCT:** Medpulser Electroporation with Bleomycin
- **PROCEDURE:** Surgical Excision

## Key facts

- **NCT ID:** NCT00198328
- **Lead sponsor:** Inovio Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 84 (ACTUAL)
- **Why stopped:** Enrollment was stopped based on the Data Monitoring Committee's recommendation.
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198328, "Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00198328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*